XENE's three largest insider shareholders as of March 23, 2026 are Frank A Holler (Director, 143.65K shares), Michael R Hayden (Director, 116.21K shares), Michael M Tarnow (Director, 77.94K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Frank A Holler | 143,653 | 0 | 01 Jun, 2021 | |
| Michael R Hayden | 116,206 | 0 | 20 May, 2021 | |
| Michael M Tarnow | 77,942 | 0 | 20 May, 2021 | |
| Mohammad Azab | 74,225 | 0 | 20 Dec, 2023 | |
| Dawn Svoronos | 25,000 | 0 | 24 Aug, 2023 | |
| Gary Patou | 23,573 | 0 | 22 Nov, 2024 | |
| Ian Mortimer | President Ceo | 19,923 | 0 | 13 Mar, 2026 |
| Ian Mortimer | President Ceo | 14,731 | 0 | 11 Mar, 2026 |
| James R. Empfield | Evp, Drug Discovery | 10,000 | 0 | 16 Aug, 2022 |
| Sherrington Robin | Evp, Strategy Innovation | 8,398 | 0 | 08 Mar, 2024 |
| Andrea Difabio | Chief Legal Officer | 7,301 | 0 | 13 Mar, 2026 |
| Steven Gannon | 7,141 | 0 | 06 Jun, 2025 | |
| Christopher John Kenney | Chief Medical Officer | 7,069 | 0 | 13 Mar, 2026 |
| Simon N. Pimstone | 6,000 | 0 | 01 Jun, 2023 | |
| Gary Patou | 0 | 4,902 | 15 Dec, 2023 | |
| Andrea Difabio | Chief Legal Officer | 4,893 | 0 | 11 Mar, 2026 |
| Christopher John Kenney | Chief Medical Officer | 4,729 | 0 | 11 Mar, 2026 |
| Seggern Christopher Von | Chief Commercial Officer | 4,000 | 0 | 07 Dec, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Christopher John Kenney | Common Shares | A | 3,750 | - | 8,479 | D | M |
| 12 Mar, 2026 | Andrea Difabio | Common Shares | A | 3,750 | - | 8,643 | D | M |
| 12 Mar, 2026 | Ian Mortimer | Common Shares | A | 12,500 | - | 27,231 | D | M |
| 13 Mar, 2026 | Andrea Difabio | Common Shares | D | 1,342 | $55.23 | 7,301 | D | S |
| 13 Mar, 2026 | Ian Mortimer | Common Shares | D | 7,308 | $55.23 | 19,923 | D | S |
| 13 Mar, 2026 | Christopher John Kenney | Common Shares | D | 1,410 | $55.23 | 7,069 | D | S |
| 12 Mar, 2026 | Christopher John Kenney | Restricted Share Units | D | 3,750 | $0.00 | 11,250 | D | M |
| 12 Mar, 2026 | Andrea Difabio | Restricted Share Units | D | 3,750 | $0.00 | 11,250 | D | M |
| 12 Mar, 2026 | Ian Mortimer | Restricted Share Units | D | 12,500 | $0.00 | 37,500 | D | M |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | A | 75,000 | $8.40 | 81,000 | D | M |
| 09 Mar, 2026 | Christopher John Kenney | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Andrea Difabio | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Christopher John Kenney | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | A | 75,000 | $8.40 | 81,000 | D | M |
| 09 Mar, 2026 | Andrea Difabio | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | D | 21,791 | $58.81 | 59,209 | D | S |
| 10 Mar, 2026 | Christopher John Kenney | Common Shares | D | 2,771 | $60.11 | 4,729 | D | S |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | D | 21,791 | $58.81 | 59,209 | D | S |
| 10 Mar, 2026 | Andrea Difabio | Common Shares | D | 2,607 | $60.11 | 4,893 | D | S |
| 10 Mar, 2026 | Andrea Difabio | Common Shares | D | 2,607 | $60.11 | 4,893 | D | S |